1. Home
  2. NKTR vs APPN Comparison

NKTR vs APPN Comparison

Compare NKTR & APPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

HOLD

Current Price

$60.25

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo Appian Corporation

APPN

Appian Corporation

HOLD

Current Price

$36.96

Market Cap

2.5B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NKTR
APPN
Founded
1990
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.5B
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
NKTR
APPN
Price
$60.25
$36.96
Analyst Decision
Strong Buy
Hold
Analyst Count
7
5
Target Price
$146.67
$29.80
AVG Volume (30 Days)
555.7K
867.6K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
101.59
EPS
N/A
N/A
Revenue
$307,711,000.00
$226,743,000.00
Revenue This Year
N/A
$13.79
Revenue Next Year
N/A
$10.56
P/E Ratio
N/A
N/A
Revenue Growth
86.00
28.29
52 Week Low
$33.40
$18.63
52 Week High
$109.00
$46.06

Technical Indicators

Market Signals
Indicator
NKTR
APPN
Relative Strength Index (RSI) 38.09 53.26
Support Level $65.14 $35.88
Resistance Level $76.63 $44.06
Average True Range (ATR) 2.76 1.81
MACD -0.69 -0.34
Stochastic Oscillator 3.33 51.23

Price Performance

Historical Comparison
NKTR
APPN

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

About APPN Appian Corporation

Appian Corp is an enterprise software company whose platform unifies process orchestration, artificial intelligence, and data for automating complex business operations. Its platform combines low-code application development, process automation and process mining, AI agents, and a data fabric that connects information across an organization's existing systems without replicating it. The company also provides maintenance and support as well as consulting services and training related to its platform. The majority of its revenue is subscription-based, with the remainder coming from services, and much of that subscription revenue comes from its cloud-based platform. Geographically, the company derives maximum revenue from its Domestic operations and also has a presence internationally.

Share on Social Networks: